You just read:

AMO Pharma Initiates Phase 2 Clinical Trial in UK for AMO-02 for Treatment of Congenital and Juvenile Onset Myotonic Dystrophy

News provided by

AMO Pharma Limited

10 Aug, 2016, 08:00 BST